about
The role of atherectomy in the treatment of lower extremity peripheral artery diseaseNon-invasive vulnerable plaque imaging: how do we know that treatment works?The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart FailureIntermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: a meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion.Epigenetic switch at atp2a2 and myh7 gene promoters in pressure overload-induced heart failure.Use of statins in lower extremity artery disease: a review.Abdominal aortic aneurysm in patients affected by intermittent claudication: prevalence and clinical predictors.Ankle/brachial index to everyoneEndovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication.Transradial approach for the endovascular treatment of type I endoleak after aortic aneurysm repair: a case report.Role of phosphoinositide 3-kinase in cardiac function and heart failure.Network integration of the adrenergic system in cardiac hypertrophy.Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure.Reversal of cardiac remodeling by modulation of adrenergic receptors: a new frontier in heart failure.Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure.Endovascular repair for isolated iliac artery aneurysms: case report and review of the current literature.Physical activity in the prevention of peripheral artery disease in the elderlyCardiovascular effects of treadmill exercise in physiological and pathological preclinical settings.Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe-gastric epithelial cells cross-talk.Meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,839 patients having transcatheter aortic valve implantation for severe aortic stenosis.Prognostic role of transthoracic echocardiography in patients affected by heart failure and reduced ejection fraction.Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients.Cardiovascular effects of histone deacetylase inhibitors epigenetic therapies: Systematic review of 62 studies and new hypotheses for future research.Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta-analysis of 5,971 patients.Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease.tURn the lights on: mitochondrial transport-RNAs and cardiovascular disease.Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure.Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation.Transient and reversible deoxyribonucleic acid damage in human left ventricle under controlled ischemia and reperfusion.Distinct effects of leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure.EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy.Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex.Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.Increased myocardial contractility and enhanced exercise function in transgenic mice overexpressing either adenylyl cyclase 5 or 8.Aortic and Mitral Calcification Is Marker of Significant Carotid and Limb Atherosclerosis in Patients with First Acute Coronary Syndrome.Unexpected preserved brain perfusion imaging despite severe and diffuse atherosclerosis of supra-aortic trunks.Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload.AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stressImpact of moderate preoperative chronic kidney disease on mortality after transcatheter aortic valve implantation
P50
Q27002637-AA5802C2-127D-4631-996D-4C4CE78EF970Q27020959-F881915F-A745-4A36-8848-959F7FE1A7DDQ28546251-03BC8A40-A99C-4F7A-8689-FF1B268163B8Q30477341-8F085569-7EB8-42DA-A0E9-8F60B450D59DQ30854056-D5D5ED6E-0BB3-43B8-86F6-71AD0DDC5A66Q34121851-A6B78D0C-96FB-4D0B-8223-96D342D94C7CQ34485974-BA7A6715-B55C-4DCF-AB03-3108895C5780Q34486065-BF090AE1-056F-4375-B5C0-D2DDDEED43F4Q34486105-BEABBA51-5C07-4F3D-B39B-766456D94DEDQ34486136-C44FA76B-D7BE-4BE3-B8C0-57439D761770Q35051158-0FCDB2C4-DE50-4A96-B790-2AEE4D1142AFQ35167505-69EEC988-F336-44E1-906C-882959A5F121Q35846897-1F510B81-13D6-4369-9FDA-F3E29F8F9487Q36522556-560FA51C-B2F9-4805-B9F7-68379A6254A8Q36925165-2C71BF26-1F8B-498B-B27D-DAE9E2548AA2Q36974257-930F7D3F-DB00-4F93-A92A-C9CCAE93E137Q37526298-680EACD1-2F81-4817-A4F6-E0B98A3BA9CEQ37612808-4882D41D-4577-4D74-BA9D-E00BD03C8525Q37864877-CF9478E8-CEBB-4B49-A41A-B2D757843963Q38110164-BF715502-A292-480A-A282-501E2D8B6497Q38236970-C6E6A2AB-B073-4D55-AD9C-C6FDC87A8A31Q38263765-20A40D71-9403-48BC-80B3-D047A4F4CD52Q38344419-54B1B636-D87E-4D14-B520-D38DB1B812C7Q38846740-CEE2C83E-7E76-4894-86D4-B66D8EAFB79EQ39044549-B09CA785-39A9-4FDB-92B8-247FC658DB7CQ39586952-5FE0BBCB-0DF2-41A5-95F0-EF744E772D15Q42406341-5504DFBF-8F32-4E40-8031-928F7CF24300Q42521411-66BB7F72-A1FA-41BF-A713-0D53841480C7Q44179202-88EBE619-E894-4028-94AA-D7A30BFDA801Q44917485-4CA4957C-469B-4E9C-9131-5792AF464173Q45103986-7736DC31-1E3A-48D6-B464-13679B42B1BEQ45197667-1C76571D-85C3-4AFD-AEC5-C9BCEBD49231Q46493544-5A24630A-D9E8-47FA-8D11-066D27064956Q46528619-B69C5525-4F02-4868-A142-FBFE76AF743DQ46885743-738A2E93-3A1F-4C90-BDC2-7C82927C00D4Q47400046-8D735F99-29D9-4315-A3FE-688EF1C115F4Q51807764-836EB694-C861-4E08-9AAC-1F166AE98D88Q53361030-20678F90-E2E8-41DC-9326-E66046AFF81CQ57599847-D45CE9B2-EADE-45F9-81A1-52053F9A5648Q57764132-7CF9788B-23BD-4CC1-97B3-43FAB6AA70E0
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cinzia Perrino
@ast
Cinzia Perrino
@en
Cinzia Perrino
@es
Cinzia Perrino
@nl
Cinzia Perrino
@sl
type
label
Cinzia Perrino
@ast
Cinzia Perrino
@en
Cinzia Perrino
@es
Cinzia Perrino
@nl
Cinzia Perrino
@sl
prefLabel
Cinzia Perrino
@ast
Cinzia Perrino
@en
Cinzia Perrino
@es
Cinzia Perrino
@nl
Cinzia Perrino
@sl
P1053
K-3183-2016
P106
P1153
35293528300
P21
P2798
P31
P3829
P496
0000-0002-2274-0048